Stocks
ALX Oncology Holdings (ALXO) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -83.4 | -122.8 | -158.4 | -132.2 | -100.8 | -100.1 | ||
| Changes by years, y/y, % | +92% | +47% | +29% | -17% | -24% | +18.3% | |||
ALX Oncology Holdings. EBITDA US GAAP, bln rub
ALX Oncology Holdings. EBITDA US GAAP, changes, %
ALX Oncology Holdings. EBITDA US GAAP, sum by quarters, bln rub
ALX Oncology Holdings (ALXO) EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EBITDA, bln rub | ? | -28.5 | -30.1 | -25.4 | -21.6 | -23.0 | -100.1 | |
| Changes by years, y/y, % | -36% | -14% | -35% | -28% | -19% | |||
| Changes by quarters, q/q, % | -5% | +6% | -16% | -15% | +7% | |||
